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Abstract
The epidemiological success of pandemic and epidemic influenza A viruses relies on the ability to transmit efficiently from
person-to-person via respiratory droplets. Respiratory droplet (RD) transmission of influenza viruses requires efficient
replication and release of infectious influenza particles into the air. The 2009 pandemic H1N1 (pH1N1) virus originated by
reassortment of a North American triple reassortant swine (TRS) virus with a Eurasian swine virus that contributed the
neuraminidase (NA) and M gene segments. Both the TRS and Eurasian swine viruses caused sporadic infections in humans,
but failed to spread from person-to-person, unlike the pH1N1 virus. We evaluated the pH1N1 and its precursor viruses in a
ferret model to determine the contribution of different viral gene segments on the release of influenza virus particles into
the air and on the transmissibility of the pH1N1 virus. We found that the Eurasian-origin gene segments contributed to
efficient RD transmission of the pH1N1 virus likely by modulating the release of influenza viral RNA-containing particles into
the air. All viruses replicated well in the upper respiratory tract of infected ferrets, suggesting that factors other than viral
replication are important for the release of influenza virus particles and transmission. Our studies demonstrate that the
release of influenza viral RNA-containing particles into the air correlates with increased NA activity. Additionally, the
pleomorphic phenotype of the pH1N1 virus is dependent upon the Eurasian-origin gene segments, suggesting a link
between transmission and virus morphology. We have demonstrated that the viruses are released into exhaled air to
varying degrees and a constellation of genes influences the transmissibility of the pH1N1 virus.
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Introduction
Influenza A viruses pose a global threat to human health. They
circulate in animal hosts and can reassort to generate a virus to
which the human population is naı ¨ve, creating a potential
pandemic threat. Efficient person-to-person transmission of
influenza A viruses via RDs is a feature of seasonal epidemics
and of pandemics. Influenza viruses have caused several
pandemics in the past, including one in 1918 caused by an
avian-origin virus that killed 50 million people, and the most
recent pandemic occurred in the spring of 2009 [1,2]. The 2009
pandemic of swine-origin H1N1 influenza virus spread to over
215 countries from April 2009 to August 2010 and was
responsible for at least 18,000 laboratory-confirmed deaths [3].
Determination of the molecular requirements for influenza
viruses to transmit efficiently from person-to-person is an essential
contribution to our understanding of potential pandemic threats.
For example, the animal influenza viruses, avian H5N1, swine
H1N1, and swine H1N2 viruses, have sporadically infected
humans [4–8] but have not caused an influenza pandemic,
presumably because they were unable to transmit efficiently
throughout the human population.
The influenza A virus genome consists of 8 negative strand
RNA gene segments that encode at least 11 proteins. The viral
envelope is predominantly composed of the hemagglutinin (HA),
neuraminidase (NA), and matrix (M1 and M2) proteins. HA is
responsible for receptor binding and viral entry into a cell, while
NA aids in release from the infected cell by cleaving sialic acids on
the cell surface. The M1 protein lines the inside of the plasma
membrane enveloping the viral RNA and gives structure to the
virion, while M2 is an ion channel important for uncoating of the
virus in the endosome and for virus release [9,10]. The segmented
genome allows reassortment to occur in nature, enhancing the
genetic diversity of the virus. The 2009 pandemic H1N1 (pH1N1)
virus arose from a reassortment event between a North American
triple reassortant swine virus (TRS) and a Eurasian swine virus.
The Eurasian swine viruses contributed the NA and M gene
segments to the pH1N1 strain, while the remaining 6 gene
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.segments came from the TRS virus [7,11]. The pH1N1 precursor
viruses, TRS and Eurasian swine, have transmitted from pigs to
humans sporadically but secondary human cases did not occur
[5,8]. Recent studies have attempted to identify the genetic
requirements for transmission of the pH1N1 virus [12,13].
However, they did not identify the biological mechanisms by
which these gene segments confer efficient transmission. There-
fore, the biological determinants responsible for transmission of
the pH1N1 virus that are lacking in the TRS and Eurasian swine
viruses are still unknown.
Transmission of influenza virus has been studied extensively in
animal models such as guinea pigs and ferrets [14], yet the precise
mechanism or requirements for transmission are still unclear.
Previous studies have suggested that host-range determinants such
as receptor binding specificity and human-specific PB2 amino acid
residues are important for transmission [15–19]. However, recent
studies have demonstrated that these host-range determinants are
not sufficient for transmission [20,21]. Additionally, the HA
protein from both the pH1N1 and TRS viruses is from the
classical swine lineage that binds a2,6-linked sialic acids and both
of these viruses contain avian-specific amino acids 627 and 701 in
the PB2 gene, suggesting that those characteristics alone do not
determine the transmissibility of these viruses. These observations
suggest a role for other gene products in the transmissibility of the
pH1N1 virus.
Three modes of influenza virus transmission have been defined:
contact transmission, droplet spray transmission, and aerosol
transmission. Contact transmission includes direct or indirect
contact with a contaminated surface. Droplet spray transmission
refers to person-to-person transmission via larger droplets that are
deposited onto mucous membranes of the upper respiratory tract.
Aerosol transmission is person-to-person transmission via aerosols
composed of small, respirable particles that can be inhaled into the
lower respiratory tract. The relative contribution of these different
modes of transmission to person-to-person spread of influenza
viruses is not known. In our study, the term respiratory droplet
(RD) transmission includes both droplet spray and aerosol
transmission. Studies attempting to distinguish between large
and small aerosols have used aerosol samplers to measure the size
of influenza virus-containing particles released by humans. Bio-
aerosol sampling has been performed in various environmental
settings such as hospitals, airplanes, and daycare centers [22–25].
These studies suggest that humans predominantly release small
respirable particles that contain influenza virus, although larger
particles containing influenza virus were also detected.
There are three components to consider when studying RD
transmission of influenza virus: the donor, the environment, and
the recipient. The donor must be infected with a virus that
replicates efficiently in the upper respiratory tract and infectious
virus must be released into the surrounding air. Environmental
factors can alter the size, morphology, and amount of influenza
virus-containing particles present in the air that is shared by the
donor and recipient [26]. Recipients must be susceptible to viral
infection and exposed to enough infectious virus to establish a
productive infection. Modulation of any of these parameters,
including viral host-range determinants, severity of disease
symptoms, environmental temperature, humidity, and suscepti-
bility of the recipient can alter the transmissibility of a virus
[27,28].
In this study, we used viruses generated by reverse genetics and
biological isolates from human infections to explore the impact of
the Eurasian-origin NA and M gene segments on transmissibility
of the 2009 pH1N1 virus in a ferret model. We included the
pH1N1 virus, representative Eurasian and TRS viruses that are
putative precursor viruses, and a reassortant pH1N1 virus in
which the NA and M gene segments were replaced with
corresponding gene segments from a TRS virus. We found that
the Eurasian NA and M gene segments contribute to efficient
transmission of the pH1N1 virus. We used cyclone-based aerosol
samplers to assess the amount and size distribution of influenza
viral RNA-containing particles released by infected ferrets and
determined the susceptibility of ferrets to the pH1N1 and its
precursor viruses. Ferrets infected with viruses containing the
Eurasian-origin NA and M gene segments efficiently released
influenza viral RNA-containing particles into the air; this release
correlated with higher NA activity of the pH1N1 and Eurasian
viruses. Eurasian gene segments also contribute to the pleomor-
phic phenotype of the pH1N1 virus and this correlated with
efficient RD transmission, suggesting a constellation of genes was
responsible for the release of influenza virus-containing aerosols
and transmissibility of the pH1N1 virus.
Results
Eurasian-Origin Gene Segments Confer Increased
Transmission of pH1N1 Virus
RD transmission of pH1N1 virus has been shown to be highly
efficient in the ferret model, with transmission efficiency ranging
from 66% to 100% [29–31]. To assess whether the Eurasian-
origin gene segments contribute to this phenotype, we used reverse
genetics to create a recombinant pH1N1 virus and a 6:2
reassortant pH1N1 virus in which the Eurasian-origin NA and
M gene segments were replaced with the North American TRS
NA and M gene segments (Table 1). We confirmed that the
recombinant wild-type (wt) 2009 pH1N1 virus rescued by reverse
genetics behaved similarly to the biological wt virus in vitro and in
vivo (Figure S1). The titer of biological pH1N1 and recombinant
pH1N1 viruses differed in the lungs of ferrets on day 1 (Figure
S1B); however, by day 5 post-infection, viral replication in the
lungs was equivalent. Therefore, we used the recombinant 2009
pandemic virus (rec A/California/07/2009), hereafter referred to
as Rec pH1N1, as a surrogate for the biological virus in further
studies.
Author Summary
Influenza A viruses spread rapidly from person-to-person
via respiratory droplets (RDs). In this study we used a ferret
model to explore viral functions involved in RD transmis-
sion of influenza viruses. The 2009 pandemic H1N1
(pH1N1) virus originated by reassortment of a North
American triple reassortant swine (TRS) virus with a
Eurasian swine virus. Both TRS and Eurasian swine viruses
had previously caused sporadic infections in humans, but
failed to spread from person-to-person, unlike the pH1N1
virus. We evaluated the release of influenza virus-
containing aerosols and the transmissibility of the
pH1N1, TRS, and Eurasian viruses in ferrets and found
that the Eurasian-origin gene segments contributed to
efficient RD transmission of the pH1N1 virus by modulat-
ing the release of influenza viral RNA-containing particles
into the air. The increased release of viral RNA-containing
particles correlated with increased viral neuraminidase
activity and production of filamentous viral particles. These
observations enhance what we currently know about the
viral requirements for influenza virus RD transmission and
have implications for assessing the potential of novel
influenza viruses to spread.
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dent transmission cages with the Rec pH1N1 virus and the
recombinant A/California/07/2009+A/Ohio/02/2007 NA
and M (6:2 reassortant) virus. We measured viral titers in the
nasal secretions of ferrets on alternate days for 14 days and
determined levels of influenza-specific serum antibodies on day
14. A ferret was considered infected if it shed virus in the nasal
secretions or seroconverted. We found that both the Rec
pH1N1 and 6:2 reassortant virus replicated to high titers in the
nasal secretions of the infected ferrets (Figure 1A and B, left
panels). Infected ferrets shed virus for 6 days, with a mean peak
titer between 10
4.2–10
5.2 TCID50/mL on days 2 or 4 post-
infection. All four of the naı ¨ve ferrets exposed to Rec pH1N1
virus shed infectious virus in the nasal secretions. Three of the
naı ¨ve exposed ferrets shed virus from days 3 to 7 post-exposure,
with a peak titer of 10
3.2–10
3.7 TCID50/mL of virus on day 5
for two of the ferrets (Figure 1A); this pattern of viral shedding
is similar to data observed by us and others on the transmission
of the biological pH1N1 virus (Figure S1D and [32]). The
fourth ferret (naı ¨ve 4) shed virus much later than the other
three (day 9 post-exposure). Presence of influenza-specific
antibodies was found in all ferrets that shed virus in the nasal
secretions (Figure 1C). Antibody titers for naı ¨ve ferret 4 were
lower compared to the other ferrets, most likely because of the
late onset of viral shedding. Since virus was detected in all 4
naı ¨ve ferrets and they all seroconverted by HAI, we concluded
that RD transmission efficiency for the Rec pH1N1 virus was
100% in our system.
RD transmission of the 6:2 reassortant virus was less efficient;
virus was detected in the nasal secretions of two out of four naı ¨ve
ferrets (Figure 1B), with peak shedding of 10
3.2–10
3.7 TCID50/mL
on day 7 post-exposure. Influenza-specific antibodies were
detected in the ferrets that shed virus in their nasal secretions
(Figure 1C). These data demonstrate that replacement of the
Eurasian-origin gene segments in the 6:2 reassortant virus resulted
in reduced transmission efficiency.
Additionally, we observed severe weight loss in two out of four
ferrets infected with Rec pH1N1 virus and three out of four ferrets
infected with the 6:2 reassortant virus (Table S1), indicating that
disease severity, as measured by weight loss, does not correlate
with efficiency of RD transmission. Sneezing was observed in one
of four ferrets for both viruses. Interestingly, in each case the naı ¨ve
partner became infected, suggesting that generation of aerosols by
sneezing may enhance transmission.
Transmission Efficiency of the Pandemic Precursor
Viruses
To determine whether the reduced transmission efficiency
between the Rec pH1N1 and the 6:2 reassortant virus was due to
the Eurasian-origin gene segments, we evaluated the transmission
efficiency of the pandemic precursor viruses. These experiments
were conducted with swine-origin viruses that were isolated from
humans (Table 1): for the North American TRS, an isolate
obtained from an adult male in Ohio in 2007 (A/Ohio/02/2007)
[8] and for the Eurasian swine virus, a virus isolated from a child
in Thailand in 2005 (A/Thailand/271/2005) [5]. Both of these
viruses had transmitted from pigs to humans, but did not spread
from person-to-person [5,6,8].
Ferretsinfected with the A/Ohio/02/2007 (TRS)virus had much
lower titers of virus in their nasal secretions (Figure 2A) than those
infected with the Rec pH1N1 or 6:2 reassortant viruses. The peak
titer was 10
2.2 TCID50/mL for most ferrets on day 2-post infection.
However, in other experiments performed in our lab and by others,
this virus replicated to higher levels in the upper respiratory tract of
ferrets (Table 2, Figure S1A and [32]). Ferrets infected with the A/
Thailand/271/2005 (Eurasian) virus shed high titers of the virus
(Figure 2B). Peak viral shedding was observed on days 2 or 4 post-
infection, with peak titers of 10
2.95–10
4.95 TCID50/mL. A matched
non-parametrictwo-wayANOVA ofthe nasal washtiters inanimals
infected with Eurasian, pH1N1, or 6:2 reassortant virus showed no
statistical difference among these groups of viruses.
One of four ferrets each infected with either the TRS or Eurasian
viruses developed a distinctive cough, similar to croup (Table S1).
The naı ¨veferretspairedwith the croupyferret becameinfected with
influenza and shed virus in their nasal secretions, suggesting that the
aerosols released by coughing enhanced RD transmission. These
were the only ferrets that shed virus in the nasal secretions after
exposure to ferrets infected with the TRS or Eurasian viruses. As
seen with the Rec pH1N1 and 6:2 reassortant viruses, all of the
ferrets with detectable virus in the nasal secretions also produced
anti-influenza antibodies (Figure 2C). However, with both the TRS
and Eurasian viruses, one naive ferret (TRS naı ¨ve 3 and Eurasian
naı ¨ve1) that didnot shedvirus inthe nasalsecretions seroconverted.
Others have also found serologic evidence of infection in the
absence of virologic evidence in a ferret transmission model [33].
Thus, we conclude that the two pandemic precursor viruses
transmitted with 50% efficiency in ferrets. Our data demonstrate
that the Eurasian-origin NA and M gene segments are necessary,
but not sufficient, for RD transmission in our ferret model. To
Table 1. Genotype of the viruses.
Origin
Virus Derived Abbr Name PB2 PB1 PA HA NP NA M NS Reference
rec A/CA/07/2009
V4 (H1N1)
Reverse
genetics
Rec pH1N1 N. Am
avian
Human
H3N2
N. Am
avian
CS CS ERAS ERAS CS Chen Z et al
2010 [52]
rec A/CA/07/2009+A/OH/
02/07 NA and M (H1N1)
Reverse
genetics
6:2 Reassort N. Am
avian
Human
H3N2
N. Am
avian
CS CS CS CS CS This Study
A/OH/02/2007 (H1N1) Biological
isolate
TRS N. Am
avian
Human
H3N2
N. Am
avian
CS CS CS CS CS Shinde et al
2009 [8]
A/Thailand/271/
2005 (H1N1)
Biological
isolate
Eurasian ERAS ERAS ERAS CS ERAS ERAS ERAS ERAS Komadina et al
2007 [5]
Adapted from Garten et al 2009 Science [11].
Key: CS (Classical Swine); ERAS (Eurasian avian-like swine); N. Am (North American).
doi:10.1371/journal.ppat.1002443.t001
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02/2007) was not due to the lower viral replication in the
experimentally infected ferrets, we re-evaluated the replication
and transmissibility of this virus with a larger number of animals.
We confirmed the earlier finding of reduced transmissibility, even in
the face of higher titers of virus in the experimentally infected
ferrets. The TRS virus replicated to variable titers in the nasal
secretions of experimentally infected ferrets; some infected ferrets
had low titers (10
1.7–10
2.95 TCID50/mL), consistent with the titers
we had observed in the first study (Figure 2A) and others had higher
titers (10
3.7–10
3.95 TCID50/mL) of virus (Figure S2A). The peak of
viral shedding was on day 2, as previously observed. In the new
transmissionstudy,only2outof6naı ¨veanimalsbecameinfected,as
defined by isolation of virus in their nasal secretions and/or
seroconversion (Figure S2B). The reduced transmission efficiency of
the TRS virus has also been reported by others [13,32].
Additionally, since ferrets infected with the pH1N1, 6:2 reassortant,
or Eurasian virus all shed virus to similar levels, we believe that RD
transmission is not dependent upon efficient virus replication in the
nasal secretions of animals. Therefore, efficient RD transmission is
likely due to other factors suchas infectivity of the virus for the naı ¨ve
host or release of viral particles into the air.
Infectivity of the Pandemic and Precursor Viruses for
Ferrets
To determine whether the infectivity of the viruses for ferrets
varied, we determined the dose of virus at which 50% of ferrets
were infected (FID50). Ferrets were inoculated with 10,000, 100, or
10 TCID50 of virus, and infectivity was measured by the presence
of infectious virus in nasal secretions or by seroconversion. Table 2
lists the number of ferrets at each dose that were infected among
the ferrets that were inoculated with each dose. Peak virus titers
obtained from the nasal secretions are also presented in Table 2.
In this experiment, ferrets infected with the TRS virus shed virus
in the nasal wash at titers equivalent to the other viruses,
confirming that this virus has variable replication in the upper
respiratory tract of ferrets. Interestingly, administration of doses of
virus as low as 10 TCID50 resulted in peak viral titers similar to
that of 1000-fold higher doses. Based on the data presented in
Table 2, Rec pH1N1 and TRS viruses have a similar FID50, and
the 6:2 reassortant and Eurasian viruses are more infectious.
Surprisingly, all 3 animals infected with 10 TCID50 of the
Eurasian virus shed virus in nasal washes and seroconverted
(Table 2). These data demonstrate that while the pandemic virus
and its precursors may differ in their infectivity in ferrets, this does
not correlate with transmissibility of these viruses via RD
transmission.
Release of Influenza Viral RNA-containing Particles into
the Air Depends on the Presence of the Eurasian-Origin
Gene Segments
Influenza virus particles must be released into the air for RD
transmission to occur. Much work has been done recently
exploring the size distribution of particles containing influenza
Figure 1. Eurasian-origin NA and M gene segments contribute to RD transmission of the pH1N1 virus. Four ferrets were inoculated IN to
test the RD transmission of Rec pH1N1 (A) or the 6:2 reassortant (B) viruses. Nasal washes were collected on the indicated days. Each bar represents
the titer of virus from an individual ferret. Inf stands for infected ferret. The limit of detection is represented as the dashed line and is 10
0.5 TCID50 per
mL. Serum was collected on day 0 and day 14. Anti-influenza antibodies were measured by HAI and neutralization assay (C). The limit of detection is
1:10 for HAI and 1:20 for the neutralization assay. Antibody titers in the day 0 sera were below the limit of detection.
doi:10.1371/journal.ppat.1002443.g001
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studies have been done in animal models to correlate the amount
of particles released with influenza virus transmission [36,37]. To
determine the size of influenza virus particles in the air exhaled by
infected ferrets, we used cyclone-based aerosol samplers that
separate particles based on size; these samplers have previously
Figure 2. Pandemic precursor viruses transmit to 50% of exposed ferrets by RD. Four ferrets were inoculated IN to test the RD transmission
of TRS (A) or the Eurasian (B) viruses. Nasal washes were collected on the indicated days. Each bar represents the titer of virus from an individual
ferret. Inf stands for infected ferret. The limit of detection is represented as the dashed line and is 10
0.5 TCID50 per mL. Serum was collected on day 0
and day 14. Anti-influenza antibodies were measured by HAI and neutralization assay (C). The limit of detection is 1:10 for HAI and 1:20 for the
neutralization assay. Antibody titers in the day 0 sera were below the limit of detection.
doi:10.1371/journal.ppat.1002443.g002
Table 2. Infectivity of pH1N1 influenza and precursor viruses for ferrets.
Virus
Dose (TCID50)o f
virus administered
a
No.
seroconverted/total
b
No. shedding virus
(Culture pos/total)
50% ferret infectious
dose (FID50)
c
Mean peak titer in nasal
wash (log10 TCID50/mL)
10 1/3 1/3 3.2
Rec pH1N1 100 3/3 3/3 18 2.4
10,000 3/3 3/3 4.2
10 1/3 2/3 3.45
6:2 Reassort 100 3/3 3/3 18 4.95
10,000 3/3 3/3 3.7
10 1/3 1/3 4.45
TRS 100 3/3 3/3 18 3.7
10,000 3/3 3/3 4.45
10 3/3 3/3 4.3
Eurasian 100 3/3 3/3 ,10 3.7
10,000 3/3 3/3 3.6
a Virus dose delivered in 500 mL volume.
b Seroconversion was determined by HAI assay.
c If the endpoint was not reached at a dose of 10 TCID50, we assumed that at a dose of 1 TCID50 no ferrets would be infected; therefore, the FID50 value is shown as ,10.
doi:10.1371/journal.ppat.1002443.t002
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workers to influenza [22,23]. The samplers have three collection
surfaces: a 15 mL conical tube captures particles greater than
4 mm, a 1.5 mL tube captures particles between 1 and 4 mm, and
a filter traps all submicron (,1 mm) particles. The samplers were
secured to the outside of the cage, between the inner and outer
doors (Figure S3A), and the air on the infected ferret’s side of the
cage was sampled for one hour on alternate days at a rate of 3.5
liters per minute. The ferrets were undisturbed during air
sampling. The distribution of influenza viral RNA-containing
particles released by infected ferrets was determined for each virus
in the study at all 3 sizes: .4 mm (Figure 3), 1 to 4 mm (Figure 4),
and ,1 mm (Figure 5). This system does not allow for the
measurement of the total count of particles released by each ferret
nor the isolation of infectious virus because the collection tubes are
dry. However, it does allow for the quantification of particles
containing influenza viral RNA. We used this measurement as a
surrogate for the amount of viral particles present in aerosols of
various sizes. We found that ferrets predominantly released
influenza virus into the air in large particles (.4 mm) (Compare
Figures 3, 4, and 5). The duration for which the large particles
containing influenza viral RNA was detected correlated with the
length of time that virus was detected in the nasal washes of the
ferrets. In the case of the Rec pH1N1 virus, all four infected ferrets
consistently released large particles containing influenza viral
RNA for 6 days post-infection, with a peak on day 2 (Figure 3A).
Although virus was not detected in the nasal wash on day 8 post-
infection, a low level of aerosol particles containing influenza viral
RNA was observed. Ferrets infected with the Eurasian swine virus
also consistently released influenza viral RNA-containing particles
into the air, and in a larger quantity than the Rec pH1N1 infected
ferrets (Figure 3B). Ferrets infected with the 6:2 reassortant and
TRS viruses sporadically released large (.4 mm size) influenza
viral RNA-containing particles (Figure 3C and D). To compare
the trend of influenza viral RNA-containing particles released by
animals infected with these viruses, we calculated the average area
under the curve (AUC) for each virus per collection tube. We
found that AUC of the Rec pH1N1 and Eurasian viruses for the
15 mL collection tube are 5540 and 29,384 respectively. These
values are higher than those for the 6:2 reassortant and TRS
viruses, which are 1338 and 2333, respectively. These data
demonstrate that while ferrets predominantly released large
influenza viral RNA-containing particles, the ferrets infected with
Rec pH1N1 and Eurasian viruses released more than those
infected with either the TRS or 6:2 reassortant virus. A similar
phenomenon was found with the release of 1 to 4 mm-sized
particles (Figure 4). Viruses containing the Eurasian-origin gene
segments (Rec pH1N1 and Eurasian) also had a more consistent
release of influenza viral RNA-containing particles at the 1–4 mm
size (Figure 4A and B), while the TRS and 6:2 reassortant virus
had a more sporadic release of influenza viral RNA-containing
particles (Figure 4 C and D). This phenomenon was confirmed by
analysis of the average AUCs for each respective graph; the Rec
pH1N1 and Eurasian viruses had AUC values (636.5 and 5464,
respectively) higher than the TRS and 6:2 reassortant viruses
(124.8 and 59.3, respectively). Ferrets infected with pH1N1 virus
released 1–4 mm particles containing influenza viral RNA from
day 2 to 4 with a peak at day 2, while some animals infected with
the Eurasian virus released these particles consistently on days 2, 4,
and 6. Very few influenza viral RNA-containing particles were
detected 6 days post-infection (Figure 4). Although it is possible
that the sporadic release of influenza viral RNA-containing
particles from ferrets infected with the TRS virus may be linked
to the low viral titers in the nasal secretions (Figure 2A), a similar
pattern of sporadic release was also seen in the repeat experiment
of ferrets infected with the TRS virus (Figure S2C). Additionally,
ferrets infected with the 6:2 reassortant virus shed virus to high
titers in the nasal secretions and also displayed a sporadic release
of particles containing influenza viral RNA. Therefore, we
conclude that the Eurasian-origin gene segments contribute to
the release of influenza viral RNA-containing particles greater
than 1 mm.
Interestingly, the pattern of release of submicron particles
containing influenza viral RNA by the Rec pH1N1 virus was
different from the other viruses (Figure 5 A and B). Ferrets infected
with the Rec pH1N1 virus consistently released submicron
particles containing influenza viral RNA into the air, and this
release was detected at every time point tested, with a similar
amount on days 2 and 6 post-infection. Interestingly, infected
ferret number 4 released a considerable amount of submicron
particles containing influenza viral RNA on days 8 and 10 post-
infection, which correlates with the late infection of its naı ¨ve pair
(refer to Figure 1A). In contrast to the Rec pH1N1-infected ferrets,
those infected with the Eurasian virus released submicron
influenza viral RNA-containing particles only sporadically.
Infection with the TRS and 6:2 reassortant virus did not result
in release of submicron influenza viral RNA-containing particles
into the air that were detectable by our sampling system (Figure 5
C and D). There was a higher background observed in the Rec
pH1N1 infected ferrets on day 0 compared to the other viruses
that may be due to an environmental contaminant. Despite this,
the release of influenza viral RNA-containing particles from ferrets
infected with the Rec pH1N1 virus was found to be distinct from
the other viruses. A comparison of the average AUC values from
days 2 to 10 confirms this observation; the pH1N1 virus had an
AUC value of 1043 and all of the other viruses had AUC values
ranging from 56 to 59. Additionally, a two-way ANOVA found
that the difference in the amount of submicron particles that
contained influenza viral RNA released by ferrets infected with
Rec pH1N1 virus compared with all other viruses was significant.
The release of submicron influenza viral RNA-containing particles
correlates with transmission efficiency and it is tempting to
speculate that RD transmission is associated with these submicron
particles.
Overall, our air sampling studies have found that ferrets infected
with viruses that lacked the Eurasian-origin NA and M gene
segments, the TRS and 6:2 reassortant viruses, only sporadically
released influenza viral RNA-containing particles of all sizes into
the air (Figures 3, 4, and 5). This finding suggests that the
Eurasian-origin gene segments contribute to the transmissibility of
the pH1N1 virus by influencing the release of influenza viral
RNA-containing particles into the air.
Release of Influenza Viral RNA-containing Particles
Correlates with NA Activity and Virus Morphology
The neuraminidase activity of the influenza NA protein cleaves
sialic acids from the proteins on the cell surface and on the viral
surface [9]. The cleavage of sialic acids by the viral neuraminidase
aids in viral release and the prevention of viral agglutination after
release. Therefore, it is plausible that infection with a virus with a
more active NA could result in the release of more virus particles
into the air. To determine whether the activity of the Eurasian-
origin NA differs from that of the classical swine NA, we used an
enzyme-linked lectin assay to determine the neuraminidase activity
of viruses that had been normalized for infectivity using fetuin as a
substrate (Figure 6A). Viruses that contain the Eurasian NA (the
biological and recombinant pH1N1 and the Eurasian viruses) had
higher NA activity than the TRS and 6:2 reassortant viruses,
Aerosol Transmission of 2009 Pandemic H1N1 Virus
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been made previously using MUNANA as a substrate [13]. To
confirm these results, we performed a neuraminidase assay using
MUNANA as a substrate (Figure 6B). MUNANA and fetuin differ
in size; MUNANA is a short a2,6-linked sialic acid substrate while
fetuin is much larger and contains both a2,3- and a2,6-linked
sialic acids [38,39]. Since little is known about the biological
substrates cleaved by NA in vivo, it is difficult to determine which
substrates are biologically most relevant. We found that the Rec
pH1N1 virus had a lower NA activity than the biological pH1N1
virus in both assays. The consensus sequence for the NA gene was
identical for these viruses, suggesting that differences in the minor
quasispecies composition of the respective virus populations may
be the factor. Interestingly, with MUNANA, the Eurasian virus
had lower NA activity than the pH1N1 virus, suggesting that NA
proteins may have variable activity on different substrates. Our
data indicate that the pH1N1 virus has a higher neuraminidase
activity than the TRS and 6:2 reassortant viruses with both long
and short substrates, and higher neuraminidase activity than the
Eurasian virus with short substrates. These observations suggest
that NA activity correlates with the release of virus particles and
increased viral release is important for efficient RD transmission of
the pH1N1 virus.
The Eurasian swine virus contributed both the NA and M gene
segments to the pH1N1 virus and the M protein has been
implicated in determining the filamentous or spherical morphol-
ogy of influenza viruses [40–42]. Therefore, we compared the
morphology of the Rec pH1N1, 6:2 reassortant, Eurasian, and
TRS viruses by electron microscopy (Figure 7). The pH1N1 virus
has previously been reported to be pleomorphic [29] and similar
morphology was observed for the Rec pH1N1 virus (Figure 7A).
We counted 20 or more particles and found that 60% of the Rec
pH1N1 virus particles were filamentous, while the 6:2 reassortant
virus was predominantly spherical with only 4% filamentous
particles (Figure 7B). These data suggest that the Eurasian-origin
gene segments specify the pleomorphic phenotype of the pH1N1
virus. The pH1N1 precursor viruses (Eurasian and TRS) were
both predominantly spherical (Figure 7C and D), with only 9.5%
or 0% filamentous particles, respectively. Taken together, these
observations indicate that the Eurasian-origin gene segments alone
are not sufficient to specify the pleomorphic morphology of the
pH1N1 virus. The cytoplasmic tails of both HA and NA have
previously been shown to contribute to influenza viral morphology
[43]. However, the viruses used in this manuscript all contain the
classical swine HA. Therefore, it is likely that specific adaptations
in the pH1N1 viral gene segments that are distinct from the
Eurasian swine gene segments have arisen and these changes may
have contributed to the pleomorphic nature of the pH1N1 virus.
Additionally, the complete passage history of the Eurasian virus is
not known but may be relevant to its morphology.
Previous studies have suggested that receptor specificity
correlates with RD transmission [17,44]. However, all of the
viruses tested in this study have HA proteins that are evolutionarily
similar to the classical swine virus (Table 1) and are antigenically
Figure 3. The Eurasian-origin NA and M gene segments contribute to abundant release of large (.4 mm) particles containing
influenza virus. Quantitative (Q)-PCR for influenza A M gene in RNA extracted from the 15 mL collection tube of the cyclone-based air samplers. Air
was collected for one hour on the outside of the infected ferret cage. Each bar represents the amount of genome copies of influenza in particles
released by a single ferret infected with Rec pH1N1 (A), Eurasian (B), TRS (C), or 6:2 reassortant (D). Absolute amount of RNA was quantitated using a
standard curve of in vitro transcribed influenza M gene RNA. Inf stands for infected ferret.
doi:10.1371/journal.ppat.1002443.g003
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binding specificity using an in vitro assay with chicken RBCs
specifically sialylated with a2,3 or a2,6 sialyltransferases (Figure
S4A) and demonstrated that all of the viruses predominantly
associate with a2,6-linked sialic acids.
Since virus-receptor affinity may be altered during viral
evolution [45], we tested whether the viruses used in this study
differed in their affinity for the a2,6 receptor by measuring their
ability to agglutinate chicken red blood cells (RBCs) that had been
treated with varying amounts of neuraminidase (Figure S4B). We
found that all of the viruses bound to RBCs that were desialylated
with similar concentrations of bacterial neuraminidase; therefore,
we conclude that neither receptor specificity nor receptor affinity
are responsible for the particle release observed in this study.
Taken together, our data suggest a role for the Eurasian-origin
segments in the morphology and NA activity of the pH1N1 virus,
one or both of which contribute to its efficient transmission.
Discussion
This study was designed to identify the molecular determinants
that confer transmissibility of the pH1N1 virus and the mechanism
by which they promote transmission. RD transmission can be
modulated at the level of the infected donor, the environment, and
the recipient. We established an RD transmission caging system
that allowed for aerosol sampling of infected ferrets. In our system,
the Rec pH1N1 virus transmitted to 100% of the naı ¨ve animals
and replacement of the NA and M gene segments with the
corresponding gene segments from TRS resulted in reduced
transmission efficiency. These findings indicate that the Eurasian-
origin NA and M gene segments contribute to the efficient
transmission of the Rec pH1N1 virus. The fact that the Eurasian
virus only transmitted to 50% of the naı ¨ve animals demonstrates
that gene constellation may influence this phenotype as it does
other properties such as virulence [46]. Yen et al. have recently
suggested that a balance between HA and the Eurasian-origin NA
contribute to the transmissibility of the pH1N1 virus [13]. Unlike
our study, they used swine isolates that had not infected humans;
therefore, any compensatory mutations that promote the initial
transmission from an animal host to human were not taken into
account. Based on our results, we believe that the biological
properties of both Eurasian-origin gene segments influence particle
release and thus efficient RD transmission. In our study, we found
that susceptibility of the recipient ferrets to the specific virus,
measured as the FID50 of the virus, did not correlate with
transmission efficiency. Since environmental factors such as
temperature and relative humidity were unaltered during the
study, they did not contribute to the transmission phenotype.
Therefore, we focused our attention on the release of influenza
viruses by the infected donor ferrets. The viruses used in this study
shared similar receptor specificity and replicated efficiently in the
upper respiratory tract of ferrets. These two factors have been
implicated in the transmissibility of other influenza viruses but they
did not contribute to the enhanced transmission phenotype of the
Figure 4. The Eurasian-origin NA and M gene segments contribute to the abundant release of 1 to 4 mm particles containing
influenza virus. Q-PCR for influenza A M gene on RNA extracted from the 1.5 mL collection tube of the cyclone-based air samplers. Air was
collected for one hour on the outside of the infected ferret cage, each bar represents the amount of particles released by a single ferret infected with
Rec pH1N1 (A), Eurasian (B), TRS (C), or 6:2 reassortant (D). Absolute RNA was quantitated using a standard curve of in vitro transcribed influenza M
gene RNA. Inf stands for infected ferret.
doi:10.1371/journal.ppat.1002443.g004
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the release of virus into the air, we found that viruses containing
the Eurasian-origin NA and M gene segments released influenza
viral RNA-containing particles into the air consistently and this
correlated with increased NA activity of these viruses. The
Eurasian-origin gene segments also conferred the pleomorphic
phenotype of the pH1N1 virus. Our observations extend our
knowledge of the molecular determinants of RD transmission and
provide an explanation for the epidemiological success of the
pH1N1 virus.
An infected donor can generate aerosols during normal
breathing or upon sneezing and coughing [47]. In our study, we
used ferrets as donors because they are highly susceptible to
influenza viruses and can both transmit the virus to humans and
acquire infection from humans [48]. Ferrets infected with
influenza viruses develop clinical symptoms such as weight loss,
Figure 5. Ferrets infected with the recombinant pH1N1 virus release submicron particles containing influenza virus. Q-PCR for
influenza A M gene on RNA extracted from the filter of the cyclone-based air samplers. Air was collected for one hour on the outside of the infected
ferret cage, each bar represents the amount of particles released by a single ferret infected with Rec pH1N1 (A), Eurasian (B), TRS (C), or 6:2 reassortant
(D). Absolute RNA was quantitated using a standard curve of in vitro transcribed influenza M gene RNA. Inf stands for infected ferret.
doi:10.1371/journal.ppat.1002443.g005
Figure 6. Viruses with Eurasian-origin NA have greater neuraminidase activity than viruses with a classical swine NA. An ELLA assay
using fetuin as a substrate was used to determine the NA activity for the biological pH1N1 (N), rec pH1N1 ( ), 6:2 reassortant (&), TRS (w), and
Eurasian (*) viruses (A). Neuraminidase activity of these viruses was also measured using MUNANA as a substrate (B). Viruses were normalized for
equal infectivity in all assays. The data are displayed as an average of 2 independent assays performed in duplicate. Error bars represent the standard
error.
doi:10.1371/journal.ppat.1002443.g006
Aerosol Transmission of 2009 Pandemic H1N1 Virus
PLoS Pathogens | www.plospathogens.org 9 December 2011 | Volume 7 | Issue 12 | e1002443sneezing, and lethargy [49]. Disease severity in ferrets and humans
varies by strain, with highly pathogenic strains such as H5N1
avian influenza viruses causing more severe disease than seasonal
influenza strains [29–31]. We found that the 2009 pH1N1 virus
and its precursor viruses caused similar disease severity in ferrets,
defined by .10% weight loss and presence of clinical symptoms
like sneezing and runny nose (Table S1). However, we also found
that one out of four ferrets infected with TRS or Eurasian viruses
developed croup and were able to efficiently transmit the virus to
their naı ¨ve partners. Upon further analysis, we found a correlation
between infected ferrets that were observed sneezing or coughing
and infection of their naı ¨ve neighbors, indicating that generation
of aerosols by sneezing and coughing enhances RD transmission.
In this study, we examined the size of influenza viral RNA-
containing particles released from ferrets infected intranasally
(IN) with influenza viruses and found that the ferrets primarily
released influenza viral RNA-containing particles greater than
4 mm in size into the air (Figure 3). Consistent with our
observations, Gustin et al. reported that anesthetized ferrets
infected IN predominantly released large (.4.7 mm) infectious
particles during normal breathing. However, they found that
ferrets infected by aerosol released much smaller (0.65 to 4.7 mm)
particles containing infectious virus into the air [37]. We found
that ferrets inoculated IN with pH1N1 and Eurasian viruses
released large (.4 mm) and small (1 to 4 mm) influenza viral
RNA-containing particles more consistently than ferrets infected
with the TRS and 6:2 reassortant viruses (Figure 3 and 4). The
viruses with more consistent release of virus had a higher NA
activity than viruses that were associated with sporadic release of
influenza viral RNA-containing particles (Figure 6). Thus, NA
activity correlates with the release of both large and small
influenza viral RNA-containing particles. However, these parti-
cles are not sufficient for efficient RD transmission since the
Eurasian virus, which consistently released large and small
influenza viral RNA-containing particles, transmitted to only
50% of the naı ¨ve animals (Figure 2B). Additionally, in animals
infected with the TRS virus, we only detected the presence of
large particles containing influenza viral RNA in the air, yet this
virus transmitted to 50% of the naı ¨ve animals. These data suggest
that the large particles (.4 mm) may contribute to RD
transmission of viruses in the ferret model system. Release of
large particles containing influenza has been observed in human
clinical studies [23]. However, the relative importance of these
particles in human transmission is unclear.
Interestingly, release of submicron influenza viral RNA-
containing particles differed between pH1N1 and the Eurasian
viruses (Figure 5). The Rec pH1N1 infected ferrets consistently
released submicron influenza viral RNA-containing particles while
ferrets infected with the Eurasian virus did not. Given that the
animal cages have a continuous air flow rate of 40 cubic feet per
minute, it is also possible that we were unable to thoroughly
capture the submicron particles released by the ferrets by sampling
on the outside of the cage. Aerosol sampling in different
environments suggests that humans predominantly release small,
respirable particles that likely result in the respiratory or aerosol
transmission of influenza viruses [22,23,34]. Since the pH1N1
infected ferrets released more submicron particles than ferrets
infected with any of the other viruses, it is possible that the
submicron particles are responsible for the efficient aerosol
transmission of the pH1N1 virus.
Previous studies have demonstrated a role for HA receptor
binding specificity and specific amino acid residues in the PB2
protein on RD transmission of influenza A viruses [17–19,50].
The emergence and transmissibility of the 2009 pH1N1 virus
cannot be explained by these molecular determinants of
transmissibility of the virus via RDs. Instead, our study illustrates
the importance of the NA and M proteins in the transmissibility of
the pH1N1 virus. We found that NA activity correlates with the
release of particles greater than 1 mm in size and this may be
necessary, but not sufficient, for RD transmission. Additionally, we
found that viral morphology correlated with transmissibility of
swine-origin viruses in the ferret model. The pleomorphic Rec
pH1N1 virus was more efficiently transmitted than the spherical
6:2 reassortant, TRS, and Eurasian viruses, suggesting that this
phenotype may be important for RD transmission of swine-origin
viruses. While there are many examples of a2,6-specific receptor
binding influenza viruses that do not transmit in animal models or
in the human population [14,51], there are no reports of RD
transmission of a2,3-specific receptor binding influenza viruses.
Therefore, virus receptor binding specificity is also necessary, but
not sufficient, for transmission.
Our data indicate that in order to more accurately assess
pandemic threat potential, phenotypes that are important for
transmission such as viral replication in the upper respiratory tract
of ferrets, release of respirable influenza virus-containing particles,
and receptor specificity of novel influenza viruses should be
characterized.
Materials and Methods
Ethics Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
National Institutes of Health and MedImmune Animal Care and
Use Committee (ACUC) approved the animal experiments that
were conducted at the respective facilities. All efforts were made to
minimize suffering.
Figure 7. Eurasian-origin gene segments confer filamentous
morphology of pH1N1 virus. Electron micrographs of negatively
stained virus preparations are shown for Rec pH1N1 (A), 6:2 reassortant
(B), TRS (C), and Eurasian (D) viruses. Representative images are shown
for each virus. Bar; 100 nm.
doi:10.1371/journal.ppat.1002443.g007
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Madin-Darby canine kidney (MDCK) cells, obtained from the
ATCC, were maintained in minimum essential media (MEM) and
10% fetal bovine serum (FBS). 293T cells, obtained from ATCC,
were maintained in Dulbecco’s MEM with 10% FBS.
The reverse genetics system for generating the 2009 pandemic
H1N1 virus (A/California/07/2009) were previously described
[52]. The NA and M gene segments for the North American TRS
virus (A/Ohio/02/2007) were constructed as previously described
[52]. The recombinant viruses generated from the reverse genetics
plasmids were rescued from MDCK/293T cell co-culture and
propagated in specific pathogen free (SPF) embryonated eggs as
described [53] for 2 passages. Viruses generated by reverse
genetics were confirmed by genomic sequencing. The A/Ohio/
02/2007 (H1N1) and A/Thailand/271/2005 (H1N1) viruses were
obtained from the Centers for Disease Control and Prevention
(CDC) and were subsequently propagated in MDCK cells. The
passage histories for the biological isolates are C5 and CX,C3/
C2/C2 for A/Ohio/02/2007 and A/Thailand/271/2005, re-
spectively where X indicates an unknown number of passages.
Ferret Infections and Nasal Wash Collection
All transmission studies consisted of four RD transmission cages,
3 male cages and 1 female cage. Each transmission cage contained
two ferrets – 1 naı ¨ve and 1 infected, per cage (Figure S3). For each
study 6 male and 2 female, 5–8 month old adult ferrets obtained
from Triple F farms (Sayre, PA) that were seronegative for
seasonal H3 and H1 viruses, and all of the viruses used in this
study. As in other RD transmission studies [27,33,51] the sample
size is small. Ferrets were inoculated intranasally (IN) with 10
6.5
TCID50 of virus in 500 mL of Leibovitz-15 medium. All ferrets
were monitored for clinical signs including sneezing, coughing,
lethargy, weight loss, and body temperature changes. In
accordance with NIAID Animal Care and Use Committee
(ACUC) guidelines, ferrets were euthanized if they lost more than
20% of their initial body weight.
Ferret infectivity studies were performed at MedImmune
(Mountain View, CA). Two male and one female adult ferrets
(5–6 month old) were inoculated IN with each dose (10, 100, or
10,000 TCID50 per 500 mL) of virus. Ferrets were considered
infected if one of the following criteria was met: detection of virus
in nasal secretions or by the presence of .40 influenza-specific
antibody titer in the sera. Ferret infectious dose 50 (FID50) values
were calculated using the method described by Reed and Muench
[54].
Nasal secretions were collected by washing the right nostril of an
anesthetized ferret with sterile PBS and 500 mL of liquid that was
expelled from the left nostril was collected. These nasal secretions
were analyzed for the presence and titer of infectious viruses and
expressed as 50% tissue culture infectious doses (TCID50) per mL.
Transmission Studies
We designed the caging system for transmission studies based on
earlier reports [33]. Briefly, large stainless steel ventilated ferret
cages from Allentown (Allentown, New Jersey) were modified for
the RD transmission studies (Figure S3). Two perforated stainless
panels were welded together, 0.5 inches apart, and placed into the
cage with a floor and ceiling guide to stabilize the panel. A door,
with separate feeder and water bottles on each side of the dividing
panel, was manufactured for each cage. Infected ferrets were
placed into the section of the cage closest to the air inlet one day
prior to infection. One day post-infection, a naı ¨ve ferret was
placed into the cage on the other side of the divider.
Environmental conditions inside the laboratory were monitored
daily and were consistently 1961uC and 5662% relative
humidity. The transmission experiments were conducted in the
same room, to minimize any effects of caging and airflow
differences on aerobiology. Nasal washes were collected and
clinical signs were recorded on alternate days for 14 days. Air
samples were collected between 9 am to 12 pm on alternate days
for 10 days. On day 14 post-infection, blood was collected from
each animal for serology. The naı ¨ve ferret was always handled
before the infected ferret. Great care was taken during nasal wash
collections and husbandry to ensure no direct contact occurred
between the ferrets.
Serology
Ferret sera were tested for the presence of anti-influenza
antibodies by hemagglutination inhibition (HAI) assay using
turkey red blood cells (RBC) and neutralization assay using
MDCK cells as described previously [53,55]. Ferrets were
considered to have seroconverted if the antibody titer was higher
than the limit of detection. The limit of detection is 1:10 for the
HAI assay and 1:20 for the neutralization assay.
Aerosol Particle Sampling
Aerosol sampling of the ferret cages was performed between 9
am and 12 pm on alternate days for 10 days, prior to nasal wash
collection. The air samples were collected by placing cyclone-
based air samplers (BC251) developed by the National Institute for
Occupational Safety and Health (Morgantown, WV) [22] on the
outside of the infected side of the ferret transmission cage. A
designated air sampler was used for each ferret to reduce cross-
contamination between animals. A baseline or day 0 reading was
obtained on the infected ferrets prior to inoculation and 24 hrs
after the animal was placed into the transmission cage. Air was
sampled for one hour at a flow rate of 3.5 liters per minute. The
aerosol sampler flow rate was calibrated before each use using a
flow meter (TSI 4100 series). The NIOSH BC251 samplers
separate particles based upon size. Each sampler contained an
empty 15 mL conical that collected particles greater than 4 mm, a
1.5 mL conical that collected particles between 1–4 mm, and a
3 mm pore Fluoropore membrane filter (Millipore) to collect
submicron particles.
Processing of the samplers was performed in a bio-safety
cabinet; 500 mL of Ambion RNA lysis binding buffer was placed
into each collection tube and vortexed vigorously. RNA was
extracted from each collection tube on a QIAGEN EZ Robot
using the QIAGEN EZ1 virus mini kit, per the manufacturer’s
recommendations. The total amount of influenza RNA was
quantified using Applied Biosystems Taqman one-step RT-PCR
kit with primers (F – 59AGATGAGTCTTCTAACCGAGG-
TCG39, and R - 59GCAAAGACATCTTCAAGTCTCTG39)
and a probe (FAM-TCA GGC CCC CTC AAA GCC GA–
[NFQ]) specific for the influenza A M gene segment. In vitro
transcribed RNA corresponding to this region of the M gene
segment was used as a standard for absolute quantification. The
RNA standard was created by, linearizing a pCDNA3.1 plasmid
containing the T7 promoter and M gene sequences of influenza
virus strain A/Beijing/262/95. This DNA was used as templates
with the MEGAScript In Vitro Transcript Kit (Ambion) to
generate Flu A M gene transcript. Transcripts were purified by
extraction with Phase Lock Gel (PLG) (Heavy) tubes (Eppendorf
Scientific, Inc.) two times, followed by phenol/chloroform,
chloroform extraction and ethanol precipitation. The dried RNA
pellet was resuspended in RNase-free RNA storage buffer (1 mM
sodium citrate, pH 6.4; Ambion). The concentration of the
purified transcript was determined by measuring absorbance at
Aerosol Transmission of 2009 Pandemic H1N1 Virus
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storage buffer was performed to generate transcript at the level of
5610
6 down to 5 copies/mL.
The limit of detection of the NIOSH BC251 samplers is
unknown. After each use, the BC251 samplers were decontam-
inated by first rinsing each sampler with distilled water, making
sure to wash the air inlet and other holes, then washing the
samplers with isopropanol, again running the alcohol through the
air inlet and all other holes.
Neuraminidase Activity
Activity of the NA protein of each virus was determined using a
peanut-agglutinin based enzyme-linked lectin assay (ELLA). The
ELLA assay was slightly modified from a previously described
assay [56]. The ELLA assay uses fetuin as a substrate for the viral
neuraminidase. Viruses were normalized for infectivity, 10
6.5
TCID50 per 500 mL, prior to performing the assay. Neuramini-
dase activity using MUNANA as a substrate was preformed using
the NA star kit obtained from Applied Biosystems, and following
the manufacturers instructions.
Electron Microscopy for Virus Morphology
A 2 mL aliquot of each stock virus, described in the ‘Viruses’
section, was concentrated by ultra-centrifugation using a Beckman
Coulter L-100 XP ultracentrifuge with a SW-55i rotor. Viruses
were pelleted at 24K rpm for 2 hrs; the pellet was resuspended in
20 mL of 1x Karnovsky’s fixative solution. Concentrated viruses
were sent to the Electron Microscopy unit at Rocky Mountain
Laboratory (Hamilton, MT) for negative stain and analysis.
Freshly glow discharged Formvar-carbon coated copper grids
(Ted Pella, Inc., Redding, CA) were submerged in droplets of each
sample and incubated overnight at 4 degrees C in a humid
chamber. The grids were washed three times for 5 min each in
deionized water, and negatively stained for 15 sec with methyl-
amine tungstate (Nanoprobes, Inc., Brookhaven, NY). The grids
were examined at 80 kV on a Hitachi H7500 transmission
electron microscope. Digital images were captured on an HR-100
CCD camera (Advanced Microscopy Techniques, Danvers, MA),
and rendered using Adobe PhotoShop (Adobe Systems, Inc., San
Jose, CA). The percent filamentous particles were calculated by
counting over 20 particles for each virus from blind pictures taken
randomly on the grid.
Supplemental Methods
In vitro replication kinetics. MDCK cells were infected
with each virus at an MOI of 0.1 and supernatant from infected
cells in triplicate was collected at 8, 24, 30, and 48 hours post-
infection. Supernatants were titrated on MDCK cells by serial
dilution as previously described [57].
In vivo replication kinetics. Replication of viruses in the
upper and lower respiratory tract of 8–12 wk old ferrets was
determined as previously described [53]. Each ferret was
inoculated IN with 10
6 TCID50 of virus in 500 mL. Nasal
turbinates and lung sections were harvested on 1 and 5 days
post infection. Viral titers in each organ were determined as
previously described [57].
Influenza receptor binding assay. Receptor specificity was
determined using an in vitro receptor binding assay as described
previously [58]. Chicken RBCs (Lampire Biological Laboratories
Inc) were desialylated with Clostridium perfringens neuraminidase
(SIGMA). The desialylated RBC were resialylated using specific
a2,3 (SIGMA) or a2,6 (Calbiochem) sialyltransferases. Viruses
known to bind specifically to a2,3- and a2,6-linked sialic acids
were used as controls for each experiment.
Receptor affinity assay. The affinity of a virus was
determined as previously described [45]. Briefly, chicken RBCs
(Lampire Biological Laboratories Inc) were treated with serial
dilutions of Clostridium perfringens neuraminidase (SIGMA) to
remove sialic acids. Agglutination of RBCs treated with the
different neuraminidase concentrations was determined using a
standard amount of each virus (4 HAU).
Supporting Information
Figure S1 The Rec pH1N1 virus behaves like the
biological pH1N1. Ferrets, 6–8 weeks old, were infected with
either Rec pH1N1 or biological pH1N1. Virus titers were
measured on days 1 and 5 post infection in the nasal turbinates
(A) or lung (B). MDCK cells were infected with biological or Rec
pH1N1 and virus titers were determined at the time indicated (C).
Transmission efficiency of the biological pH1N1 virus was
determined using 3 transmission cages with 6 adult ferrets (D).
(TIFF)
Figure S2 Reduced transmission and release of parti-
cles containing influenza viral RNA from ferrets
infected with TRS virus. Six ferrets were inoculated IN to
test the RD transmission of TRS. Nasal washes were collected
on the indicated days (A). Each bar represents the titer of virus
from an individual ferret. Inf stands for infected ferret. The limit
of detection is represented as the dashed line and is 10
0.5
TCID50 per mL. Serum was collected on day 0 and day 14.
Anti-influenza antibodies were measured by HAI and neutral-
ization assay (B). The limit of detection is 1:10 for HAI and 1:20
for the neutralization assay. Antibody titers in the day 0 sera
were below the limit of detection. Aerosol sampling was
performed on four of the infected animals (Inf 1–4) to determine
the presence of particles containing influenza viral RNA (C).
Each bar represents an individual animal. Absolute RNA was
quantified using a standard curve of in vitro transcribed
influenza M gene RNA.
(TIFF)
Figure S3 Schematic of respiratory droplet transmis-
sion cage setup. Commercially available cages from Allentown
were modified to prevent direct contact between the two ferrets. A
top-down view of the modified cage illustrates the location of the
infected and naı ¨ve ferret in relation to the airflow (A). A door
containing separate water and feeding tray for each ferret (B) and a
perforated stainless steel panel (C) prevented any contact between
the ferrets.
(TIFF)
Figure S4 The 2009 pandemic H1N1 virus and precur-
sors share receptor specificity and affinity. An in vitro
receptor-binding assay using desialylated chicken RBCs was used
to determine the receptor binding of the Rec pH1N1, 6:2
reassortant, TRS, and Eurasian swine viruses (A). Viruses with
differential receptor specificity, previously identified by MedIm-
mune, were used as controls in the receptor-binding assay. The
a2,3 standard is A/Japan/305/1957 (H2N2) Q226, G228 and the
a2,6 standard is A/Japan/305/1957 (H2N2) L226, S228.
Receptor affinity was assessed by agglutination of partially
desialylated RBCs (B). Viruses defined previously to have
differential receptor affinity [59] were used as standards.
(TIFF)
Table S1 Summary of clinical signs in infected and
naı ¨ve ferrets.
(DOC)
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